Meldungen sortieren nach Relevanz Meldungsdatum
|
Neue Erkenntnisse über Genregulation und Skelettentwicklung
, Forschung und Entwicklung, Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch
Die Patienten haben verkürzte Mittelhand- und Mittelfußknochen und können kleinwüchsig sein. Sie haben eine Skelettfehlbildung, Brachydaktylie Typ E (griech. für...
|
International Cartilage Repair Society 2nd Annual Foot & Ankle Focus Meeting
, Events, Cartilage Executive Office GmbH
The International Cartilage Repair Society (ICRS) today announced several important educational events for clinicians, basic scientists, and industry representatives...
|
International Cartilage Repair Society 10th World Congress To Focus On Cartilage Biotech, Stem Cell Research & Tissue Engineering
, Events, Cartilage Executive Office GmbH
Final details were announced today for the 10th World Congress of the International Cartilage Repair Society, to be held at the Hotel Fairmont Queen Elizabeth in...
|
New Jersey Institute of Technology 2nd Annual Biotech/Life Sciences Industry Forum
, Forschung und Entwicklung, New Jersey Institute of Technology
New Jersey Institute of Technology's Dept of Biomedical Engineering in collaboration with Career Development Services, will host its 2nd Annual Biotech/Life Sciences...
|
Roche's Cellavista System Performs Cell Analytics for a Novel Automated High Throughput Cell Culture Platform for Regenerative Medicine
, Biotechnik, Roche Diagnostics GmbH
Regenerative medicine is dependent on advances in tissue engineering, biochemistry and applied bioengineering to develop and produce cells and cell-based products...
|
Optimisation of implants
The second specialist 'Medical Technology' forum on 24 May in Erfurt is dedicated to the production of implants using differing Rapid Manufacturing (RM) processes....
|
Higher, faster, smarter
The demand for generative processes is continuously growing in the automobile industry, medical and dental technology and also in the aviation industry. Parts with...
|
Both mobile and stable
, Medizintechnik, TRUMPF GmbH + Co. KG
The number of hip and knee joint implant operations is on the rise. In 2009 alone a total of 210,000 patients received endoprosthetic hip replacements in Germany....
|
Galapagos Starts Phase II Clinical Trial in Rheumatoid Arthritis Patients
, Biotechnik, Galapagos
Galapagos NV (Euronext: GLPG) announced today that it has started a Phase II clinical study for the Company's flagship program GLPG0259, a novel drug being developed...
|
4SC Provides Enrolment Update for Phase IIb Rheumatoid Arthritis Study with Vidofludimus (4SC-101)
, Forschung und Entwicklung, 4SC AG
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced that the company...
|
Cytori Issued Celution(R) System Patent for Orthopedic & Spinal Disc Diseases
, FirmenIntern, Cytori Therapeutics, Inc.
Cytori Therapeutics (NASDAQ: CYTX) has received U.S. Patent No. 7,771,716 (the '716 patent) for Celution(R) System based methods of treating musculoskeletal disorders...
|
The Future is in Cells
, Forschung und Entwicklung, BINDER Central Services GmbH & Co. KG
Never say never again. This James Bond movie title certainly applies to medical research. Only a few years ago, cultivating joint cartilage tissue for transplants...
|
Förderpreis für Erlanger Handchirurgen
, Forschung und Entwicklung, Friedrich-Alexander-Universität Erlangen-Nürnberg
Für die Erforschung der Knorpel-Zellerholung bei Verschleißerscheinungen im Handgelenksdiskus wird Dr. Frank Unglaub aus der Plastisch- und Handchirurgischen Klinik...
|
|
4SC Announces First Patient Treated in Phase IIb Rheumatoid Arthritis Study with 4SC-101
, Medizintechnik, 4SC AG
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced the dosing of the first patient in its Phase IIb trial evaluating...
|
Successful cell-free products - highly promising new start-up in the Life Science Center Esslingen
, Medizintechnik, BioRegio STERN Management GmbH
The cell biologist Dr. Thomas Graeve has founded Amedrix GmbH in Esslingen. In future, the company will develop and produce innovative, cell-free medical products...
Ähnliche Keywords
Firmen
Kategorien
Alle Kategorien
